Humacyte, Inc.
Status: Publicly traded
Direct answer
Humacyte, Inc. is publicly traded on NASDAQ under the ticker HUMA.
Humacyte, Inc. focuses on developing and manufacturing readily available, implantable human tissues engineered in a laboratory setting. These bioengineered tissues are designed to treat a wide array of diseases and conditions across various anatomical locations and therapeutic fields. The company employs its distinct scientific and proprietary technology platform to produce human acellular vessels (HAVs). These...
Can you invest in Humacyte, Inc.?
Yes. Humacyte, Inc. is publicly traded on NASDAQ under the ticker HUMA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Humacyte, Inc.
Detailed equity research is provided by MarketSnap.